While it has been previously reported that AREG is overexpressed in ovarian cancer (Lindzen et al., 2021) and is associated with advanced stage disease (Tung et al., 2017), using bioinformatic analyses we failed to observe an association between AREG expression and patient survival. This evidence concerns the gene AREG and ovarian carcinoma.